• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

矢状面图像融合的加入改善了基于传感器的MRI/超声融合引导靶向活检中前列腺癌的检测。

The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy.

作者信息

Günzel Karsten, Cash Hannes, Buckendahl John, Königbauer Maximilian, Asbach Patrick, Haas Matthias, Neymeyer Jörg, Hinz Stefan, Miller Kurt, Kempkensteffen Carsten

机构信息

Department of Urology, Charité - University Medicine Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.

Departement of Radiology, Charité - University Medicine Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.

出版信息

BMC Urol. 2017 Jan 13;17(1):7. doi: 10.1186/s12894-016-0196-9.

DOI:10.1186/s12894-016-0196-9
PMID:28086856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234255/
Abstract

BACKGROUND

To explore the diagnostic benefit of an additional image fusion of the sagittal plane in addition to the standard axial image fusion, using a sensor-based MRI/US fusion platform.

METHODS

During July 2013 and September 2015, 251 patients with at least one suspicious lesion on mpMRI (rated by PI-RADS) were included into the analysis. All patients underwent MRI/US targeted biopsy (TB) in combination with a 10 core systematic prostate biopsy (SB). All biopsies were performed on a sensor-based fusion system. Group A included 162 men who received TB by an axial MRI/US image fusion. Group B comprised 89 men in whom the TB was performed with an additional sagittal image fusion.

RESULTS

The median age in group A was 67 years (IQR 61-72) and in group B 68 years (IQR 60-71). The median PSA level in group A was 8.10 ng/ml (IQR 6.05-14) and in group B 8.59 ng/ml (IQR 5.65-12.32). In group A the proportion of patients with a suspicious digital rectal examination (DRE) (14 vs. 29%, p = 0.007) and the proportion of primary biopsies (33 vs 46%, p = 0.046) were significantly lower. The rate of PI-RADS 3 lesions were overrepresented in group A compared to group B (19 vs. 9%; p = 0.044). Classified according to PI-RADS 3, 4 and 5, the detection rates of TB were 42, 48, 75% in group A and 25, 74, 90% in group B. The rate of PCa with a Gleason score ≥7 missed by TB was 33% (18 cases) in group A and 9% (5 cases) in group B; p-value 0.072. An explorative multivariate binary logistic regression analysis revealed that PI-RADS, a suspicious DRE and performing an additional sagittal image fusion were significant predictors for PCa detection in TB. 9 PCa were only detected by TB with sagittal fusion (sTB) and sTB identified 10 additional clinically significant PCa (Gleason ≥7).

CONCLUSION

Performing an additional sagittal image fusion besides the standard axial fusion appears to improve the accuracy of the sensor-based MRI/US fusion platform.

摘要

背景

使用基于传感器的MRI/US融合平台,探讨除标准轴向图像融合外,增加矢状面图像融合的诊断益处。

方法

在2013年7月至2015年9月期间,纳入251例在mpMRI上至少有一个可疑病变(根据PI-RADS评级)的患者进行分析。所有患者均接受了MRI/US靶向活检(TB)及10针系统前列腺活检(SB)。所有活检均在基于传感器 的融合系统上进行。A组包括162名通过轴向MRI/US图像融合接受TB的男性。B组包括89名在TB时进行了额外矢状面图像融合的男性。

结果

A组的中位年龄为67岁(IQR 61-72),B组为68岁(IQR 60-71)。A组的中位PSA水平为8.10 ng/ml(IQR 6.05-14),B组为8.59 ng/ml(IQR 5.65-12.32)。A组中直肠指检(DRE)可疑的患者比例(14%对29%,p = 0.007)和初次活检比例(33%对46%,p = 0.046)显著较低。与B组相比,A组中PI-RADS 3类病变的比例过高(19%对9%;p = 0.044)。根据PI-RADS 3、4和5分类,A组TB的检出率分别为42%、48%、75%,B组分别为25%、74%、90%。A组TB漏诊的Gleason评分≥7的前列腺癌(PCa)比例为33%(18例),B组为9%(5例);p值0.072。一项探索性多变量二元逻辑回归分析显示,PI-RADS、DRE可疑以及进行额外的矢状面图像融合是TB中PCa检测的重要预测因素。9例PCa仅通过矢状面融合TB(sTB)检测到,sTB还发现了另外10例具有临床意义的PCa(Gleason≥7)。

结论

除标准轴向融合外,增加矢状面图像融合似乎可提高基于传感器的MRI/US融合平台的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/5234255/6dd6d91591cc/12894_2016_196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/5234255/6dd6d91591cc/12894_2016_196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee25/5234255/6dd6d91591cc/12894_2016_196_Fig1_HTML.jpg

相似文献

1
The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy.矢状面图像融合的加入改善了基于传感器的MRI/超声融合引导靶向活检中前列腺癌的检测。
BMC Urol. 2017 Jan 13;17(1):7. doi: 10.1186/s12894-016-0196-9.
2
Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.经直肠超声引导下随机活检发现前列腺癌,尽管实时磁共振成像/超声融合引导下靶向活检结果为阴性:靶向活检失败的原因
BJU Int. 2016 Jul;118(1):35-43. doi: 10.1111/bju.13327. Epub 2015 Oct 20.
3
Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.确定男性是否适合仅进行磁共振成像/超声融合引导下靶向活检而无需额外系统活检的预测参数。
Urol Int. 2017;98(1):15-21. doi: 10.1159/000449258. Epub 2016 Sep 13.
4
[Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].[实时磁共振成像/超声融合引导活检提高了先前活检患者前列腺癌的检出率]
Aktuelle Urol. 2014 May;45(3):197-203. doi: 10.1055/s-0034-1375682. Epub 2014 Jun 5.
5
Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.多参数磁共振成像-经直肠超声融合引导下徒手经会阴靶向前列腺活检在既往活检阴性且前列腺特异性抗原升高的中国男性中的评估
BMC Urol. 2017 Jul 5;17(1):52. doi: 10.1186/s12894-017-0241-3.
6
Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.原发性磁共振成像/超声融合引导前列腺活检。
BJU Int. 2018 Aug;122(2):211-218. doi: 10.1111/bju.14212. Epub 2018 Apr 17.
7
Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.联合超声/磁共振多参数融合引导活检与系统性超声活检获得的组织学结果分析:磁共振多参数成像在前列腺癌检测及假阴性中的作用
Radiol Med. 2018 Feb;123(2):143-152. doi: 10.1007/s11547-017-0814-y. Epub 2017 Oct 10.
8
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.活检前多参数磁共振成像(MRI)、活检指征与MRI-超声融合靶向前列腺活检结果之间的关系
Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.
9
[Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].[既往前列腺穿刺活检阴性患者的多参数磁共振成像及磁共振成像-经直肠超声融合活检]
Urologe A. 2016 Aug;55(8):1071-7. doi: 10.1007/s00120-016-0093-6.
10
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.在MRI/经直肠超声融合活检中,显著前列腺癌的检测与前列腺影像报告和数据系统(PI-RADS)相关。
World J Urol. 2016 Apr;34(4):525-32. doi: 10.1007/s00345-015-1671-8. Epub 2015 Aug 21.

引用本文的文献

1
Assessing the diagnostic accuracy of unilateral systematic biopsy combined with targeted biopsy.评估单侧系统活检联合靶向活检的诊断准确性。
Front Oncol. 2025 Aug 19;15:1599869. doi: 10.3389/fonc.2025.1599869. eCollection 2025.
2
Optimizing the strategies to perform prostate biopsy in MRI-positive patients: a systematic review and network meta-analysis.优化MRI阳性患者前列腺活检策略:一项系统评价和网状Meta分析
EClinicalMedicine. 2025 Mar 22;82:103164. doi: 10.1016/j.eclinm.2025.103164. eCollection 2025 Apr.
3
Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions.

本文引用的文献

1
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.多参数磁共振成像(MRI)和 MRI-经直肠超声融合活检用于检测起始肿瘤:与根治性前列腺切除术标本的相关性。
Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.
2
Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.磁共振-超声融合活检在前列腺癌检测中的应用:系统活检与靶向活检的作用
Cancer. 2016 Mar 15;122(6):884-92. doi: 10.1002/cncr.29874. Epub 2016 Jan 7.
3
基于不同的 csPCa 定义,各种前列腺取样方案对临床显著前列腺癌(csPCa)的检测。
BMC Urol. 2021 Dec 23;21(1):183. doi: 10.1186/s12894-021-00949-7.
4
Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer.PI-RADS 版本 2.1 与版本 2.0 对检测外周带和移行区前列腺癌的诊断性能比较。
Sci Rep. 2020 Sep 29;10(1):15982. doi: 10.1038/s41598-020-72544-z.
5
Comparison of prostate cancer detection rates between magnetic resonance imaging-targeted biopsy and transrectal ultrasound-guided biopsy according to Prostate Imaging Reporting and Data System in patients with PSA ≥4 ng/mL: a systematic review and meta-analysis.根据前列腺影像报告和数据系统,对PSA≥4 ng/mL患者进行磁共振成像靶向活检与经直肠超声引导活检的前列腺癌检出率比较:一项系统评价和荟萃分析。
Transl Androl Urol. 2019 Dec;8(6):741-753. doi: 10.21037/tau.2019.12.03.
6
Image fusion using hybrid methods in multimodality medical images.基于混合方法的多模态医学图像的图像融合。
Med Biol Eng Comput. 2020 Apr;58(4):669-687. doi: 10.1007/s11517-020-02136-6. Epub 2020 Jan 28.
[Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
[MRI/超声融合技术在前列腺癌初次活检诊断中的价值]
Urologe A. 2016 Feb;55(2):146-55. doi: 10.1007/s00120-015-3980-3.
4
Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.经直肠超声引导下随机活检发现前列腺癌,尽管实时磁共振成像/超声融合引导下靶向活检结果为阴性:靶向活检失败的原因
BJU Int. 2016 Jul;118(1):35-43. doi: 10.1111/bju.13327. Epub 2015 Oct 20.
5
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.在MRI/经直肠超声融合活检中,显著前列腺癌的检测与前列腺影像报告和数据系统(PI-RADS)相关。
World J Urol. 2016 Apr;34(4):525-32. doi: 10.1007/s00345-015-1671-8. Epub 2015 Aug 21.
6
Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.前瞻性随机临床试验比较了磁共振成像(MRI)引导的腔内活检与 MRI-超声融合和经直肠超声引导的前列腺活检在先前阴性活检患者中的应用。
Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.
7
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.一项随机对照试验,旨在评估和比较融合磁共振和经直肠超声图像引导的双芯前列腺活检与传统 12 芯系统活检的结果。
Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.
8
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.多参数磁共振成像能否检测到有临床意义的前列腺癌?文献系统评价。
Eur Urol. 2015 Dec;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. Epub 2015 Feb 2.
9
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.MR/超声融合引导活检与超声引导活检诊断前列腺癌的比较。
JAMA. 2015 Jan 27;313(4):390-7. doi: 10.1001/jama.2014.17942.
10
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.